SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-22-009305
Filing Date
2022-04-07
Accepted
2022-04-06 21:59:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 76256
  Complete submission text file 0001493152-22-009305.txt   77603
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Subject) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81115 | Film No.: 22812188
SIC: 2834 Pharmaceutical Preparations

Mailing Address 117 E. 29TH ST. APT. 5A NEW YORK NY 10016
Business Address
FORMAN ERIC (Filed by) CIK: 0001650389 (see all company filings)

Type: SC 13G/A